NCT01567995View on ClinicalTrials.gov

Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

February 28, 2008

Primary Completion Date

January 1, 2009

Study Completion Date

February 10, 2009

Conditions
Eczema
Interventions
DRUG

Clobetasone Butyrate 0.05% Cream

Clobetasone Butyrate 0.05% Cream

DRUG

Vehicle (base cream)

Vehicle (base cream)

Trial Locations (7)

100034

GSK Investigational Site, Beijing

100044

GSK Investigational Site, Beijing

100730

GSK Investigational Site, Beijing

200040

GSK Investigational Site, Shanghai

210029

GSK Investigational Site, Nanjing

210042

GSK Investigational Site, Nanjing

300052

GSK Investigational Site, Tianjin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY